XML 53 R17.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Other Expense (Income), Net | 9 Months Ended
--- | ---
Feb. 28, 2013
Other Expense (Income), Net | NOTE 11 — OTHER EXPENSE (INCOME), NET Other expense (income), net, consists of the following components:
|  | Three Months Ended |  |  | Nine Months Ended |
|  | February 28, 2013 |  |  | February 29, 2012 |  |  | February 28, 2013 |  |  | February 29, 2012 |
(In thousands) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Royalty (income), net |  | $ | (848 | ) |  | $ | (438 | ) |  | $ | (1,574 | ) |  | $ | (1,175 | )
Loss on Brazil operational repositioning |  |  | 6,087 |  |  |  | — |  |  |  | 6,087 |  |  |  | — |
Loss on Kemrock conversion option |  |  | — |  |  |  | — |  |  |  | 9,030 |  |  |  | — |
(Income) loss related to unconsolidated equity affiliates |  |  | (525 | ) |  |  | (961 | ) |  |  | 40,287 |  |  |  | (7,194 | )
Other expense (income), net |  | $ | 4,714 |  |  | $ | (1,399 | ) |  | $ | 53,830 |  |  | $ | (8,369 | )
Equity in Income of Unconsolidated Affiliates Beginning with our fiscal year ended May 31, 2007, we began purchasing shares of Kemrock Industries and Exports Limited (“Kemrock”) common stock. Kemrock is one of India’s leading manufacturers of high performance reinforced polymer composites, and is also part of a strategic alliance with certain of our subsidiaries for licensed manufacturing and supply of molded and pultruded gratings. By May 31, 2011, we had acquired a total of approximately 3.2 million shares of Kemrock common stock, for an accumulated cost approximating $24.2 million, which represented approximately 18% of Kemrock’s outstanding shares at that time. Our investment in Kemrock common stock had been classified in other long-term assets on our balance sheet and included with available-for-sale securities, which are carried at fair value based on quoted market prices. During fiscal 2012, we purchased approximately 870,000 additional shares of Kemrock common stock, which increased our ownership to 23% of Kemrock’s outstanding shares. Also during fiscal 2012, we entered into a GDR Purchase Agreement with Kemrock, whereby we purchased from Kemrock 693,072 GDRs of Kemrock for an aggregate purchase price of approximately $7.2 million. We account for our investment in the Kemrock GDRs as common stock equivalents within our total investment in Kemrock. Lastly, during fiscal 2012 we invested $22.7 million in 5.5% convertible bonds issued by Kemrock. The bonds are convertible into ordinary shares or GDRs, each representing one ordinary share of Kemrock stock, and may be converted at any time on or after June 4, 2012 and up to the close of business on June 12, 2017. Our investment in Kemrock convertible bonds is accounted for as an available-for-sale security and is classified in other long-term assets in our Consolidated Balance Sheet. The convertible feature embedded in the convertible bonds is accounted for as a derivative under the guidance in ASC 815, “Derivatives and Hedging.” Due to the presumption under GAAP that an entity with an ownership percentage greater than 20% has significant influence, and no other factors would refute that presumption, we changed our accounting for this investment to the equity method. Adjustments are made to our investment in order to recognize our share of Kemrock’s earnings as they occur, rather than as dividends or other distributions are received. Any changes in our proportionate share of the underlying equity of Kemrock, which could result from their issuance of additional equity securities, are recognized as increases or decreases in shareholders’ equity, net of any related tax effects. We account for our equity method investment in Kemrock under ASC 323, “Investments – Equity Method and Joint Ventures.” As outlined in ASC 323-10-35-32, a decline in the quoted market price below the carrying amount when combined with other evidence of a loss in value may be indicative of a loss in value that is other than temporary. Acting upon the premise that a write-down of our investment in Kemrock may be required, we considered all available evidence to evaluate the realizable value of our equity investment, including a decline in the market price of shares of Kemrock stock, the financial condition and near term prospects of Kemrock, and the overall economic situation in India. As a result of these factors, we determined that it was appropriate to record an impairment loss during first half of fiscal 2013 of approximately $42.2 million on our equity method investment and a loss of approximately $9.0 million for the write-down of the embedded conversion derivative associated with our investment in Kemrock convertible bonds. The loss is classified in other (income) expense, net in our Consolidated Statements of Income. Please refer to 2, where information related to this investment is more fully described. Our investment in Kemrock is reported in our Consolidated Balance Sheet at its adjusted carrying value and classified as a long-term asset. Our investment in Kemrock had no carrying value at February 28, 2013 and a carrying value of $42.2 million at May 31, 2012. Loss on Repositioning of Operations in Brazil During the third quarter of fiscal 2013, we repositioned certain of our industrial segment operations in Brazil, resulting in a substantial liquidation of a subsidiary and a loss of approximately $6.1 million. Included in the loss was the write-off of the associated accumulated foreign currency translation. This non-cash charge was previously recorded as an unrealized foreign exchange loss in our currency translation account as a component of other comprehensive income.

X
- Definition Schedule of other income and expense, including royalty income, net, equity in income from unconsolidated affiliates and gain/loss on derivatives. + References No definition available. + Details
Name: | rpm_ScheduleOfOtherIncomeExpenseNetTextBlock
Namespace Prefix: | rpm_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration